New York Patent of the Month – September 2023

Nanotronics Health, LLC, a subsidiary of Nanotronics, is leveraging Intelligent Factory Control (IFC) to build affordable and reliable medical devices. With this approach, the company has developed and patented a new non-invasive positive airway pressure (PAP) device, marketed as nHale™. 

Non-invasive ventilation is often used for patients experiencing respiratory distress or suffering from conditions such as Obstructive Sleep Apnea (OSA) and Chronic Obstructive Pulmonary Disorder (COPD). Nanotronics Health’s solution includes a blower capable of delivering a carefully calibrated vapor to the patient. What sets this device apart is its versatility, with the primary housing being configurable between two positions.

In the first position, a lid selectively shields a second electronic connection portion, ensuring the device remains secure and protected during transportation or storage. However, when switched to the second position, the outer edge of the primary housing takes over, forcefully opening the lid and allowing the first electronic connection portion to mate with the second electronic connection portion. This ingenious design simplifies the setup process, making it more user-friendly for both patients and healthcare providers.

The device incorporates advanced sensors that measure both pressure and temperature in real time, ensuring precise therapy delivery and patient comfort. This data is then communicated to a controller that fine-tunes the therapy based on the patient’s needs, thereby optimizing treatment effectiveness.

The humidification system within the device includes a water reservoir and a heating plate, ensuring that the delivered vapor is appropriately conditioned for patient comfort. In addition, an ultraviolet light sterilizes the liquid, enhancing hygiene during therapy sessions.

Safety is a top priority, as demonstrated by the inclusion of a valve that prevents asphyxiation during therapy, providing peace of mind for patients and their caregivers.

Are you developing new technology for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.

Who We Are:

Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.

Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at or contact your usual Swanson Reed representative.

Recent Posts